{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:18:19Z","timestamp":1787872699088,"version":"build-2784847793"},"reference-count":35,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Formation of denser and poorly lysable fibrin networks characterizes patients with left atrial appendage thrombus (LAAT) of unknown origin. Elevated factor (F)XI is associated with thromboembolism, including left ventricular thrombus. We investigated whether FXI is increased in LAAT and might predispose to its recurrence and complications.<\/jats:p>\n                  <jats:p>In a case\u2013control study, we studied 36 consecutive patients with LAAT of unknown origin following thrombus resolution, versus 36 age-, sex-, and diabetes-matched controls, all without current anticoagulant treatment. Plasma FXI levels were assessed, along with von Willebrand factor (vWF), clot permeability (Ks), clot lysis time (CLT), fibrinolysis proteins, thrombin generation, and platelet markers. Ischemic cerebrovascular events and LAAT recurrence were evaluated during a median follow-up of 10 years.<\/jats:p>\n                  <jats:p>FXI levels were 14% higher in the LAAT group compared with controls (p\u2009&lt;\u20090.001). FXI &gt;120% was more common in the former group (p\u2009=\u20090.0015). Current smoking and fibrinogen were associated with FXI &gt;120%. In LAAT patients, FXI correlated positively with fibrinogen and CLT, while inversely with vWF and Ks. Most recurrent LAAT (n\u2009=\u200910 out of 11 in total) or cerebrovascular events (n\u2009=\u200918 out of 23 in total) occurred in patients with baseline FXI &gt;120% (both p\u2009&lt;\u20090.001). FXI was associated with LAAT recurrence (OR for 10%\u2009=\u20092.73, 95% CI: 1.32\u20135.66) and cerebrovascular events (OR for 10%: 1.79, 95% CI: 1.06\u20133.04).<\/jats:p>\n                  <jats:p>Higher FXI is associated with LAAT of unknown origin, its recurrence and occurrence of cerebrovascular events following anticoagulation withdrawal. Further studies are needed to evaluate whether FXI may help identify patients with LAAT who require prolonged anticoagulation.<\/jats:p>","DOI":"10.1055\/a-2703-4109","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T23:05:29Z","timestamp":1759187129000},"page":"911-918","source":"Crossref","is-referenced-by-count":1,"title":["Elevated Factor XI is Associated with First and Recurrent Left Atrial Appendage Thrombus of Unknown Origin"],"prefix":"10.1055","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5452-6178","authenticated-orcid":false,"given":"Aleksandra","family":"Bana\u015b","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4560-1080","authenticated-orcid":false,"given":"Szymon","family":"Glanowski","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-308X","authenticated-orcid":false,"given":"Micha\u0142","family":"Z\u0105bczyk","sequence":"additional","affiliation":[{"name":"Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland"},{"name":"Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-9407","authenticated-orcid":false,"given":"El\u017cbieta","family":"Paszek","sequence":"additional","affiliation":[{"name":"Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland"},{"name":"Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-1724","authenticated-orcid":false,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[{"name":"Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland"},{"name":"Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ehjci\/jeab139","article-title":"Left atrial appendage thrombus and cerebrovascular events post-transcatheter aortic valve implantation","volume":"23","author":"M P van Wiechen","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5603\/CJ.a2022.0054","article-title":"Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation","volume":"31","author":"J Karwowski","year":"2024","journal-title":"Cardiol J"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12959-023-00478-3","article-title":"Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk","volume":"21","author":"Y Qiao","year":"2023","journal-title":"Thromb J"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41598-023-27622-3","article-title":"Left atrial appendage thrombus formation, potential of resolution and association with prognosis in a large real-world cohort","volume":"13","author":"M Hautmann","year":"2023","journal-title":"Sci Rep"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.echo.2013.05.017","article-title":"Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?","volume":"26","author":"D Alyeshmerni","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.STR.0000154858.27353.df","article-title":"Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study","volume":"36","author":"D Erdogan","year":"2005","journal-title":"Stroke"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/STROKEAHA.116.012856","article-title":"Prothrombotic state in patients with a left atrial appendage thrombus of unknown origin and cerebrovascular events","volume":"47","author":"R Meus","year":"2016","journal-title":"Stroke"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0040-1710013","article-title":"Role of factor XIa and plasma kallikrein in arterial and venous thrombosis","volume":"120","author":"M Visser","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11239-023-02935-2","article-title":"Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study","volume":"57","author":"E Paszek","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"109086","DOI":"10.1016\/j.thromres.2024.109086","article-title":"Elevated plasma factor XI is associated with postthrombotic syndrome","volume":"241","author":"K St\u0119pie\u0144","year":"2024","journal-title":"Thromb Res"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jtha.2023.02.031","article-title":"Predictive value for increased activated factor XI activity in acute venous thromboembolism","volume":"21","author":"M Nagy","year":"2023","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2022.02.009","article-title":"Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients","volume":"346","author":"E Paszek","year":"2022","journal-title":"Atherosclerosis"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"e14196","DOI":"10.1111\/eci.14196","article-title":"Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin","volume":"54","author":"\u0141 Zandecki","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/euje.2000.0066","article-title":"Guidelines from the Working Group. Recommendations for performing transesophageal echocardiography","volume":"2","author":"F A Flachskampf","year":"2001","journal-title":"Eur J Echocardiogr"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/STROKEAHA.115.009528","article-title":"Altered fibrin clot properties in patients with cerebral venous sinus thrombosis: association with the risk of recurrence","volume":"46","author":"J Siudut","year":"2015","journal-title":"Stroke"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"38","key":"ref17","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/asheducation-2014.1.66","article-title":"Epidemiologic and clinical data linking factors XI and XII to thrombosis","volume":"2014","author":"N S Key","year":"2014","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"36","key":"ref19","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/QC259F09UNMKVP0R","article-title":"Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events","volume":"126","author":"D T Yang","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1038\/s41598-022-13174-5","article-title":"Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis","volume":"12","author":"A Pallares Robles","year":"2022","journal-title":"Sci Rep"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12933-023-01905-5","article-title":"Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study","volume":"22","author":"E Paszek","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5551\/jat.RV22015","article-title":"Cigarette smoking and atherosclerotic cardiovascular disease","volume":"31","author":"M Ishida","year":"2024","journal-title":"J Atheroscler Thromb"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s10439-016-1771-7","article-title":"Differential roles for the coagulation factors XI and XII in regulating the physical biology of fibrin","volume":"45","author":"J L Sylman","year":"2017","journal-title":"Ann Biomed Eng"},{"issue":"12","key":"ref25","first-page":"16884","article-title":"Novel factors affecting fibrin clot formation and their clinical implications","volume":"134","author":"M Z\u0105bczyk","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"ref26","first-page":"17945","article-title":"Incredible fibrin(ogen): from basic mechanisms to clinical implications","volume":"77","author":"M Z\u0105bczyk","year":"2025","journal-title":"Prz Lek Jagiellonian Med Rev"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/rth2.12186","article-title":"BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics","volume":"3","author":"D Thomas","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"ref28","first-page":"16799","article-title":"Factor XI inhibition in cardiovascular disease","volume":"134","author":"S Carlin","year":"2024","journal-title":"Pol Arch Intern Med"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2407105","article-title":"Asundexian versus apixaban in patients with atrial fibrillation","volume":"392","author":"J P Piccini","year":"2025","journal-title":"N Engl J Med"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/jth.15236","article-title":"Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"19","author":"A TP Ngo","year":"2021","journal-title":"J Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/a-2525-4219","article-title":"Changes in coagulation factor XI activity levels in patients with ST-segment elevation myocardial infarction undergoing primary PCI","author":"M Spagnolo","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"108056","DOI":"10.1016\/j.cmpb.2024.108056","article-title":"Fluid-structure interaction analysis of the thromboembolic risk in the left atrial appendage under atrial fibrillation: Effect of hemodynamics and morphological features","volume":"246","author":"G Musotto","year":"2024","journal-title":"Comput Methods Programs Biomed"},{"issue":"08","key":"ref33","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/STROKEAHA.118.023124","article-title":"Intrinsic coagulation pathway, history of headache, and risk of ischemic stroke","volume":"50","author":"H JA van Os","year":"2019","journal-title":"Stroke"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"L Drabik","year":"2015","journal-title":"Thromb Res"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"L A Sposato","year":"2015","journal-title":"Lancet Neurol"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2703-4109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:41:40Z","timestamp":1787870500000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2703-4109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":35,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2703-4109","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}